NASDAQ:FATE
$5.92
(
11.70%
)
Friday, 27th Jan 2023
Fate Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.02 | $11.44 | Friday, 27th Jan 2023 FATE stock ended at $5.92. This is 11.7% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 14.48% from a day low at $5.25 to a day high of $6.01. |
| 90 days | $4.02 | $23.96 | |
| 52 weeks | $4.02 | $43.12 |
Historical Fate Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $5.29 | $6.01 | $5.25 | $5.92 | 2 768 809 |
| 2023-01-26 | $5.48 | $5.49 | $5.16 | $5.30 | 1 946 675 |
| 2023-01-25 | $5.34 | $5.45 | $5.17 | $5.40 | 2 599 180 |
| 2023-01-24 | $5.42 | $5.60 | $5.35 | $5.43 | 2 643 405 |
| 2023-01-23 | $5.59 | $5.68 | $5.33 | $5.55 | 3 929 416 |
| 2023-01-20 | $5.78 | $5.80 | $5.45 | $5.47 | 3 041 388 |
| 2023-01-19 | $5.77 | $5.88 | $5.59 | $5.65 | 2 785 538 |
| 2023-01-18 | $5.78 | $5.91 | $5.60 | $5.81 | 3 120 214 |
| 2023-01-17 | $5.73 | $5.86 | $5.57 | $5.72 | 4 293 339 |
| 2023-01-13 | $5.83 | $5.90 | $5.38 | $5.40 | 3 002 631 |
| 2023-01-12 | $5.73 | $5.87 | $5.35 | $5.86 | 2 612 842 |
| 2023-01-11 | $5.49 | $5.78 | $5.32 | $5.72 | 3 940 100 |
| 2023-01-10 | $5.15 | $5.49 | $5.07 | $5.49 | 5 737 300 |
| 2023-01-09 | $4.32 | $5.57 | $4.30 | $5.27 | 14 466 800 |
| 2023-01-06 | $4.38 | $4.55 | $4.02 | $4.24 | 33 525 200 |
| 2023-01-05 | $11.24 | $11.44 | $10.54 | $11.00 | 3 850 967 |
| 2023-01-04 | $10.42 | $11.40 | $10.38 | $11.12 | 7 446 980 |
| 2023-01-03 | $9.94 | $10.75 | $9.92 | $10.17 | 10 036 766 |
| 2022-12-30 | $9.85 | $10.20 | $9.56 | $10.09 | 6 496 750 |
| 2022-12-29 | $10.01 | $10.16 | $9.79 | $10.00 | 9 019 407 |
| 2022-12-28 | $10.14 | $10.44 | $9.79 | $9.86 | 3 383 656 |
| 2022-12-27 | $10.90 | $11.07 | $9.88 | $10.20 | 3 754 089 |
| 2022-12-23 | $11.66 | $11.67 | $10.89 | $11.01 | 2 501 052 |
| 2022-12-22 | $11.55 | $11.75 | $10.95 | $11.66 | 3 330 524 |
| 2022-12-21 | $12.75 | $13.00 | $12.15 | $12.25 | 1 984 568 |
| 2022-12-20 | $12.64 | $12.88 | $12.41 | $12.63 | 1 753 253 |
| 2022-12-19 | $13.08 | $13.15 | $12.43 | $12.75 | 2 164 668 |
| 2022-12-16 | $14.00 | $14.11 | $12.94 | $13.08 | 5 375 978 |
| 2022-12-15 | $14.49 | $15.05 | $13.91 | $14.21 | 2 257 586 |
| 2022-12-14 | $16.33 | $16.43 | $15.21 | $15.37 | 2 144 976 |
| 2022-12-13 | $17.35 | $17.63 | $15.35 | $16.37 | 2 856 401 |
| 2022-12-12 | $16.88 | $17.01 | $14.84 | $16.20 | 4 890 842 |
| 2022-12-09 | $19.00 | $19.57 | $18.71 | $18.90 | 752 484 |
| 2022-12-08 | $19.42 | $19.42 | $18.57 | $19.12 | 1 126 692 |
| 2022-12-07 | $19.01 | $19.40 | $18.79 | $19.10 | 966 364 |
| 2022-12-06 | $20.40 | $20.73 | $19.03 | $19.14 | 1 133 796 |
| 2022-12-05 | $20.90 | $21.10 | $20.02 | $20.40 | 1 112 663 |
| 2022-12-02 | $19.79 | $20.93 | $19.48 | $20.91 | 1 366 245 |
| 2022-12-01 | $20.88 | $21.47 | $19.95 | $20.34 | 836 626 |
| 2022-11-30 | $19.98 | $21.07 | $19.41 | $20.82 | 1 423 453 |
| 2022-11-29 | $19.34 | $20.71 | $19.13 | $19.84 | 1 420 774 |
| 2022-11-28 | $19.73 | $20.14 | $19.11 | $19.26 | 713 695 |
| 2022-11-25 | $19.42 | $19.99 | $19.15 | $19.83 | 333 978 |
| 2022-11-23 | $19.76 | $20.74 | $19.50 | $19.65 | 813 604 |
| 2022-11-22 | $19.65 | $19.68 | $18.86 | $19.55 | 610 202 |
| 2022-11-21 | $19.68 | $20.07 | $19.28 | $19.40 | 446 753 |
| 2022-11-18 | $20.63 | $20.63 | $19.73 | $19.79 | 569 576 |
| 2022-11-17 | $20.10 | $20.41 | $19.66 | $19.87 | 588 714 |
| 2022-11-16 | $21.92 | $22.05 | $20.18 | $20.50 | 935 346 |
| 2022-11-15 | $23.35 | $23.96 | $21.90 | $22.58 | 747 691 |
About Fate Therapeutics
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
